Exact Mass: 311.1288

Exact Mass Matches: 311.1288

Found 151 metabolites which its exact mass value is equals to given mass value 311.1288, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

IMAZAQUIN

IMAZAQUIN

C17H17N3O3 (311.127)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7950; ORIGINAL_PRECURSOR_SCAN_NO 7948 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7948; ORIGINAL_PRECURSOR_SCAN_NO 7947 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3770; ORIGINAL_PRECURSOR_SCAN_NO 3769 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3779; ORIGINAL_PRECURSOR_SCAN_NO 3778 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3762; ORIGINAL_PRECURSOR_SCAN_NO 3761 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3761; ORIGINAL_PRECURSOR_SCAN_NO 3760 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7928; ORIGINAL_PRECURSOR_SCAN_NO 7927 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7919; ORIGINAL_PRECURSOR_SCAN_NO 7918 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7962; ORIGINAL_PRECURSOR_SCAN_NO 7957 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3745; ORIGINAL_PRECURSOR_SCAN_NO 3744 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3711

   

Domoic acid

4-[(2E,4Z)-6-carboxy-6-methylhexa-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Isodomoic acid F is found in mollusks. Isodomoic acid F is isolated from mussels. Isolated from mussels. Isodomoic acid F is found in mollusks.

   

Citalopram alcohol

Citalopram alcohol

C19H18FNO2 (311.1322)


   
   

Isodomoic acid A

Isodomoic acid A

C15H21NO6 (311.1369)


An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,5-dien-2-yl group at position 4. It is isolated from the red alga, Chondria armata. D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

   

Tolazamide

Tolazamide

C14H21N3O3S (311.1304)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4274; ORIGINAL_PRECURSOR_SCAN_NO 4272 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4225; ORIGINAL_PRECURSOR_SCAN_NO 4223 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4245; ORIGINAL_PRECURSOR_SCAN_NO 4243 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4316; ORIGINAL_PRECURSOR_SCAN_NO 4314 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4224; ORIGINAL_PRECURSOR_SCAN_NO 4220 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8447; ORIGINAL_PRECURSOR_SCAN_NO 8445 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8470; ORIGINAL_PRECURSOR_SCAN_NO 8469 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8494; ORIGINAL_PRECURSOR_SCAN_NO 8491 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8497; ORIGINAL_PRECURSOR_SCAN_NO 8496 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8468; ORIGINAL_PRECURSOR_SCAN_NO 8463 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8506; ORIGINAL_PRECURSOR_SCAN_NO 8504

   

N2N2-Dimethylguanosine

N2,N2-Dimethylguanosine

C12H17N5O5 (311.123)


CONFIDENCE standard compound; INTERNAL_ID 311 N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.

   
   

N2,N2-Dimethylguanosine

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(dimethylamino)-6,9-dihydro-3H-purin-6-one

C12H17N5O5 (311.123)


N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. The mean levels of urinary N2,N2-Dimethylguanosine in the patients with colorectal cancer are significantly higher than those in patients with intestinal villous adenoma or the healthy adults (PMID 15991285). N2,N2-Dimethylguanosine has been identified in the human placenta (PMID: 32033212). N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.

   

1,7-Dimethylguanosine

2-amino-9-[(2R,3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-oxidooxolan-2-yl]-1,7-dimethyl-6-oxo-6,7-dihydro-1H-9λ⁵-purin-9-ylium

C12H17N5O5 (311.123)


1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216) [HMDB] 1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216).

   

Tolazamide

N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulphonamide

C14H21N3O3S (311.1304)


Tolazamide is only found in individuals that have used or taken this drug. It is a sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide. [PubChem]Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents

   

5-(N,N-Hexamethylene)amiloride

3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide

C12H18ClN7O (311.1261)


D000970 - Antineoplastic Agents

   

1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one

1-(4-Aminophenyl)--3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin-4-one

C17H17N3O3 (311.127)


CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].

   

Dothiepin sulfoxide

2-[3-(dimethylamino)propylidene]-9lambda4-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-9-one

C19H21NOS (311.1344)


   

(2S,3S,4S)-4-[(6S)-6-Carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2S,3S,4S)-4-[(6S)-6-Carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

Isodomoic acid B

Isodomoic acid B

C15H21NO6 (311.1369)


   

Isodomoic acid C

Isodomoic acid C

C15H21NO6 (311.1369)


   

Isodomoic acid D

Isodomoic acid D

C15H21NO6 (311.1369)


   

Isodomoic acid E

Isodomoic acid E

C15H21NO6 (311.1369)


   

O-glycosylation-IN-1

O-glycosylation-IN-1

C15H21NO6 (311.1369)


   

Maybridge4_001129

Maybridge4_001129

C19H18FNO2 (311.1322)


   
   
   

Dehydroisolongistrobine

Dehydroisolongistrobine

C17H17N3O3 (311.127)


   
   
   

Mannopinic acid

Mannopinic acid

C11H21NO9 (311.1216)


   
   

Dehydro-isolongistrobin|Dehydroisolongistrobin

Dehydro-isolongistrobin|Dehydroisolongistrobin

C17H17N3O3 (311.127)


   

spirostaphylotrichin V

spirostaphylotrichin V

C15H21NO6 (311.1369)


   

methyl 1-((2-methyl carbamate)ethyl)-beta-carboline-3-carboxylate

methyl 1-((2-methyl carbamate)ethyl)-beta-carboline-3-carboxylate

C17H17N3O3 (311.127)


   

5-(N,N-Hexamethylene)amiloride

5-(N,N-Hexamethylene)-amiloride

C12H18ClN7O (311.1261)


D000970 - Antineoplastic Agents

   

Domoic acid

(-)-domoic acid

C15H21NO6 (311.1369)


An L-proline derivative that is L-proline substituted by a carboxymethyl group at position 3 and a 6-carboxyhepta-2,4-dien-2-yl group at position 4. It is produced by the diatomic algal Pseudo-nitzschia. It is an analogue of kainic acid and a neurotoxin which causes amnesic shellfish poisoning (ASP). D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents

   

N2,N2-Dimethylguanosine

N2,N2-Dimethylguanosine

C12H17N5O5 (311.123)


   
   

N2,N2-Dimethylguanosine; LC-tDDA; CE10

N2,N2-Dimethylguanosine; LC-tDDA; CE10

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE20

N2,N2-Dimethylguanosine; LC-tDDA; CE20

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE30

N2,N2-Dimethylguanosine; LC-tDDA; CE30

C12H17N5O5 (311.123)


   

N2,N2-Dimethylguanosine; LC-tDDA; CE40

N2,N2-Dimethylguanosine; LC-tDDA; CE40

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE0; CorrDec

N,N-Dimethylguanosine; AIF; CE0; CorrDec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE10; CorrDec

N,N-Dimethylguanosine; AIF; CE10; CorrDec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE30; CorrDec

N,N-Dimethylguanosine; AIF; CE30; CorrDec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE0; MS2Dec

N,N-Dimethylguanosine; AIF; CE0; MS2Dec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE10; MS2Dec

N,N-Dimethylguanosine; AIF; CE10; MS2Dec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; AIF; CE30; MS2Dec

N,N-Dimethylguanosine; AIF; CE30; MS2Dec

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE10

N,N-Dimethylguanosine; LC-tDDA; CE10

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE20

N,N-Dimethylguanosine; LC-tDDA; CE20

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE30

N,N-Dimethylguanosine; LC-tDDA; CE30

C12H17N5O5 (311.123)


   

N,N-Dimethylguanosine; LC-tDDA; CE40

N,N-Dimethylguanosine; LC-tDDA; CE40

C12H17N5O5 (311.123)


   

N6-Methylisoeugenolyl-adenine

N6-Methylisoeugenolyl-adenine

C16H17N5O2 (311.1382)


   

1-Propanamine, N,N-dimethyl-3-(5-oxidodibenzo[b,e]thiepin-11(6H)-ylidene)-, (E)- (9CI)

1-Propanamine, N,N-dimethyl-3-(5-oxidodibenzo[b,e]thiepin-11(6H)-ylidene)-, (E)- (9CI)

C19H21NOS (311.1344)


   

N,N-HEXAMETHYLENEAMILORIDE

5-(N,N-Hexamethylene)-amiloride

C12H18ClN7O (311.1261)


   

1,7-Dimethylguanosine

1,7-Dimethylguanosine

C12H17N5O5 (311.123)


   

2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid Methyl ester

2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid Methyl ester

C15H21NO4S (311.1191)


   

(S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine

(S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine

C19H21NOS (311.1344)


   

1-(3,4-Methylenedioxyphenyl)-2-pyrrolidino-1-pentanone hydrochloride

1-(3,4-Methylenedioxyphenyl)-2-pyrrolidino-1-pentanone hydrochloride

C16H22ClNO3 (311.1288)


   

4-Cyano-3-fluorophenyl 4-pentylbenzoate

4-Cyano-3-fluorophenyl 4-pentylbenzoate

C19H18FNO2 (311.1322)


   

5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-

5-Pyrimidinecarbonitrile, 4-amino-2-(2,5-dihydroxyphenyl)-6-(3-piperidinyl)-

C16H17N5O2 (311.1382)


   

QUINOLINE-2-YL DIPHENYL METHANOL

QUINOLINE-2-YL DIPHENYL METHANOL

C22H17NO (311.131)


   

Sumatriptan N-Oxide

Sumatriptan N-Oxide

C14H21N3O3S (311.1304)


   

Boc-Cys(Bzl)-OH

Boc-Cys(Bzl)-OH

C15H21NO4S (311.1191)


   

N-[(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]-Carbamic acid 1,1-dimethylethyl ester

N-[(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]-Carbamic acid 1,1-dimethylethyl ester

C16H19F2NO3 (311.1333)


   

2-(N,N-Dimethylsulfamoyl)phenylboronic acid. pinacol ester

2-(N,N-Dimethylsulfamoyl)phenylboronic acid. pinacol ester

C14H22BNO4S (311.1363)


   

3-(N,N-Dimethylsulfamoyl)phenylboronic acid, pinacol ester

3-(N,N-Dimethylsulfamoyl)phenylboronic acid, pinacol ester

C14H22BNO4S (311.1363)


   

N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

C14H22BNO4S (311.1363)


   

N-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide

N-methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide

C14H22BNO4S (311.1363)


   

N-(4-METHOXYPHENYL)-2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-2-YL)ACETAMIDE

N-(4-METHOXYPHENYL)-2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-2-YL)ACETAMIDE

C17H17N3O3 (311.127)


   

butyl prop-2-enoate,2-methylidenebutanedioic acid,prop-2-enenitrile

butyl prop-2-enoate,2-methylidenebutanedioic acid,prop-2-enenitrile

C15H21NO6 (311.1369)


   

(1-METHYL-1H-IMIDAZOL-4-YL)METHYLAMINE

(1-METHYL-1H-IMIDAZOL-4-YL)METHYLAMINE

C22H17NO (311.131)


   

Benzyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside

Benzyl 2-acetamido-2-deoxy-alpha-D-glucopyranoside

C15H21NO6 (311.1369)


   

tert-butyl 4-fluoro-4-(methylsulfonyloxymethyl)piperidine-1-carboxylate

tert-butyl 4-fluoro-4-(methylsulfonyloxymethyl)piperidine-1-carboxylate

C12H22FNO5S (311.1203)


   

2-METHYLPHENYL 2-ACETAMIDO-2-DEOXY-β-D-GLUCOPYRANOSIDE

2-METHYLPHENYL 2-ACETAMIDO-2-DEOXY-β-D-GLUCOPYRANOSIDE

C15H21NO6 (311.1369)


   
   

3-Piperidinecarboxylicacid, 4-oxo-1-(2-phenylethyl)-, ethyl ester, hydrochloride (1:1)

3-Piperidinecarboxylicacid, 4-oxo-1-(2-phenylethyl)-, ethyl ester, hydrochloride (1:1)

C16H22ClNO3 (311.1288)


   

3-(4-chloro-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester

3-(4-chloro-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester

C16H22ClNO3 (311.1288)


   

N-α-t-Boc-S-benzyl-L-cysteine

N-α-t-Boc-S-benzyl-L-cysteine

C15H21NO4S (311.1191)


   

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide

C14H22BNO4S (311.1363)


   

6-O-tert-butyl 3-O-ethyl 5,7-dihydro-4H-thieno[2,3-c]pyridine-3,6-dicarboxylate

6-O-tert-butyl 3-O-ethyl 5,7-dihydro-4H-thieno[2,3-c]pyridine-3,6-dicarboxylate

C15H21NO4S (311.1191)


   

2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride

2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride

C16H22ClNO3 (311.1288)


   

tert-butyl 4-(2-chlorophenoxy)piperidine-1-carboxylate

tert-butyl 4-(2-chlorophenoxy)piperidine-1-carboxylate

C16H22ClNO3 (311.1288)


   

S-(+)-N,N-DIMETHYL-3-(1-NAPHTHLENYLOXY)-3-(2-THIENYL)-PROPANAMINE

S-(+)-N,N-DIMETHYL-3-(1-NAPHTHLENYLOXY)-3-(2-THIENYL)-PROPANAMINE

C19H21NOS (311.1344)


   

N-(4-TERT-BUTYLPHENYLSULFONYL)-L-PROLINE,

N-(4-TERT-BUTYLPHENYLSULFONYL)-L-PROLINE,

C15H21NO4S (311.1191)


   

(4-(1-(((Benzyloxy)carbonyl)amino)cyclopropyl)phenyl)boronic acid

(4-(1-(((Benzyloxy)carbonyl)amino)cyclopropyl)phenyl)boronic acid

C17H18BNO4 (311.1329)


   

1-ISOPENTYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-ISOPENTYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C17H17N3O3 (311.127)


   

2H-1-Benzopyran-2-one,3-[2-(diethylamino)ethyl]-7-hydroxy-4-methyl-, hydrochloride (1:1)

2H-1-Benzopyran-2-one,3-[2-(diethylamino)ethyl]-7-hydroxy-4-methyl-, hydrochloride (1:1)

C16H22ClNO3 (311.1288)


   

Ganciclovir Mono-O-propionate

Ganciclovir Mono-O-propionate

C12H17N5O5 (311.123)


   

1-N-BOC-4-(3-CHLOROPHENYL)-4-HYDROXYPIPERIDINE

1-N-BOC-4-(3-CHLOROPHENYL)-4-HYDROXYPIPERIDINE

C16H22ClNO3 (311.1288)


   

2-C-methyl-6-O-methyl-guanosine

2-C-methyl-6-O-methyl-guanosine

C12H17N5O5 (311.123)


   

(S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine

(S)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine

C19H21NOS (311.1344)


   

metahexamide

metahexamide

C14H21N3O3S (311.1304)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

ETHYL 5-BOC-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-2-CARBOXYLATE

ETHYL 5-BOC-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-2-CARBOXYLATE

C15H21NO4S (311.1191)


   

N,3-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

N,3-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

C14H22BNO4S (311.1363)


   

Benzyl 2-Acetamido-2-deoxy-β-D-glucopyranoside

Benzyl 2-Acetamido-2-deoxy-beta-D-glucopyranoside

C15H21NO6 (311.1369)


   

homatropine hydrochloride

homatropine hydrochloride

C16H22ClNO3 (311.1288)


   

4-BOC-2-(4-CHLOROPHENYL)-2-METHYLMORPHOLINE

4-BOC-2-(4-CHLOROPHENYL)-2-METHYLMORPHOLINE

C16H22ClNO3 (311.1288)


   

N6-(2-Hydroxyethyl)adenosine

N6-(2-Hydroxyethyl)adenosine

C12H17N5O5 (311.123)


N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

4-hydroxy propranolol hcl

4-hydroxy propranolol hcl

C16H22ClNO3 (311.1288)


   

2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,styrene

2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,styrene

C15H21NO4S (311.1191)


   

(R)-Imazaquin

(R)-Imazaquin

C17H17N3O3 (311.127)


   

4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine

4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine

C17H17N3O3 (311.127)


   

(S)-Imazaquin

(S)-Imazaquin

C17H17N3O3 (311.127)


   

N-{2-[(4-Cyano-1,1-biphenyl-4-YL)oxy]ethyl}-N-hydroxy-N-methylurea

N-{2-[(4-Cyano-1,1-biphenyl-4-YL)oxy]ethyl}-N-hydroxy-N-methylurea

C17H17N3O3 (311.127)


   

(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol

(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol

C15H21NO6 (311.1369)


   

N2,N2-Dimethylguanosine (incomplete stereochemisrty)

N2,N2-Dimethylguanosine (incomplete stereochemisrty)

C12H17N5O5 (311.123)


   

4-(2,5-Dimethoxyphenyl)-3-buten-2-one

4-(2,5-Dimethoxyphenyl)-3-buten-2-one

C16H17N5S (311.1205)


   

N-(7-carboxy-7-demethylgeranyl)-L-glutamate

N-(7-carboxy-7-demethylgeranyl)-L-glutamate

C15H21NO6-2 (311.1369)


   

(3R,4R,5R,6R)-3-amino-6-[2-hydroxy-2-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]ethyl]oxane-2,4,5-triol

(3R,4R,5R,6R)-3-amino-6-[2-hydroxy-2-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]ethyl]oxane-2,4,5-triol

C11H21NO9 (311.1216)


   

(3Z)-N,N-dimethyl-3-(5-oxo-6H-benzo[c][1]benzothiepin-11-ylidene)propan-1-amine

(3Z)-N,N-dimethyl-3-(5-oxo-6H-benzo[c][1]benzothiepin-11-ylidene)propan-1-amine

C19H21NOS (311.1344)


   

(2S,3S,4S)-4-[(6S)-6-Carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2S,3S,4S)-4-[(6S)-6-Carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

3-(2,3-dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)phenol

3-(2,3-dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)phenol

C22H17NO (311.131)


   

5-(2-Ethoxyphenyl)-3-(2-methoxy-6-methyl-3-pyridinyl)-1,2,4-oxadiazole

5-(2-Ethoxyphenyl)-3-(2-methoxy-6-methyl-3-pyridinyl)-1,2,4-oxadiazole

C17H17N3O3 (311.127)


   

(2-Nitro-benzylidene)-(4-pyridin-2-yl-piperazin-1-yl)-amine

(2-Nitro-benzylidene)-(4-pyridin-2-yl-piperazin-1-yl)-amine

C16H17N5O2 (311.1382)


   

2-[[(4-Methyl-2-thiazolyl)amino]-oxomethyl]-1-pyrrolidinecarboxylic acid 2-methylpropyl ester

2-[[(4-Methyl-2-thiazolyl)amino]-oxomethyl]-1-pyrrolidinecarboxylic acid 2-methylpropyl ester

C14H21N3O3S (311.1304)


   

1-(4-Methoxyphenyl)-1-methyl-3-(1-methyl-5-benzotriazolyl)urea

1-(4-Methoxyphenyl)-1-methyl-3-(1-methyl-5-benzotriazolyl)urea

C16H17N5O2 (311.1382)


   

N(6)-Dnp-Lys-NH2

N(6)-Dnp-Lys-NH2

C12H17N5O5 (311.123)


   

N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate

N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate

C12H17N5O5 (311.123)


   

1-(Para-nitrophenyl)heptamethyltrisilane

1-(Para-nitrophenyl)heptamethyltrisilane

C13H25NO2Si3 (311.1193)


   

1-(Meta-nitrophenyl)heptamethyltrisilane

1-(Meta-nitrophenyl)heptamethyltrisilane

C13H25NO2Si3 (311.1193)


   

2-(Meta-nitrophenyl)heptamethyltrisilane

2-(Meta-nitrophenyl)heptamethyltrisilane

C13H25NO2Si3 (311.1193)


   

2-(Para-nitrophenyl)-heptamethyltrisilane

2-(Para-nitrophenyl)-heptamethyltrisilane

C13H25NO2Si3 (311.1193)


   

CFM 2

1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one

C17H17N3O3 (311.127)


CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].

   

N(2),N(2)-Dimethylguanosine

N(2),N(2)-Dimethylguanosine

C12H17N5O5 (311.123)


A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups.

   

Dimethylguanosine

Dimethylguanosine

C12H17N5O5 (311.123)


   

2′-O-Methyl-8-methyl guanosine

2′-O-Methyl-8-methyl guanosine

C12H17N5O5 (311.123)


2′-O-Methyl-8-methyl guanosine (m8Gm) is a Z-form RNA stabilizer. 2′-O-Methyl-8-methyl guanosine can markedly stabilize the Z-RNA at low salt conditions[1]. m8Gm-contained oligonucleotides stabilize the Z-DNA under low salt conditions[2].

   

(2s,3s,4s)-4-[(2e,4z,6r)-6-carboxy-6-methylhexa-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2s,3s,4s)-4-[(2e,4z,6r)-6-carboxy-6-methylhexa-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

(3r,4r,5s,6s,10z)-4,6-dihydroxy-2,3-dimethoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

(3r,4r,5s,6s,10z)-4,6-dihydroxy-2,3-dimethoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C15H21NO6 (311.1369)


   

4,6-dihydroxy-4-{[5-(3-hydroxy-2-methylpropyl)-5-methyl-4-oxofuran-2-yl]methyl}-3,5-dihydropyridin-2-one

4,6-dihydroxy-4-{[5-(3-hydroxy-2-methylpropyl)-5-methyl-4-oxofuran-2-yl]methyl}-3,5-dihydropyridin-2-one

C15H21NO6 (311.1369)


   

4,6-dihydroxy-4-{[(5r)-5-[(2s)-3-hydroxy-2-methylpropyl]-5-methyl-4-oxofuran-2-yl]methyl}-3,5-dihydropyridin-2-one

4,6-dihydroxy-4-{[(5r)-5-[(2s)-3-hydroxy-2-methylpropyl]-5-methyl-4-oxofuran-2-yl]methyl}-3,5-dihydropyridin-2-one

C15H21NO6 (311.1369)


   

4-{[2-(2,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]methyl}phenol

4-{[2-(2,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]methyl}phenol

C17H17N3O3 (311.127)


   

4-(6-carboxy-6-methylhexa-2,5-dien-2-yl)-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

4-(6-carboxy-6-methylhexa-2,5-dien-2-yl)-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

2-hydroxy-3,6-dimethyl-n-[(3r,4r,5r)-4,5,6-trihydroxy-4-methyloxan-3-yl]benzenecarboximidic acid

2-hydroxy-3,6-dimethyl-n-[(3r,4r,5r)-4,5,6-trihydroxy-4-methyloxan-3-yl]benzenecarboximidic acid

C15H21NO6 (311.1369)


   

(2s,3s,4s)-4-[(5e)-6-carboxy-6-methylhexa-1,5-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2s,3s,4s)-4-[(5e)-6-carboxy-6-methylhexa-1,5-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

(2s,3s,4e)-4-[(3e,6r)-6-carboxy-6-methylhex-3-en-2-ylidene]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2s,3s,4e)-4-[(3e,6r)-6-carboxy-6-methylhex-3-en-2-ylidene]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

3-({bis[(2-oxooxolan-3-yl)methyl]amino}methyl)oxolan-2-one

3-({bis[(2-oxooxolan-3-yl)methyl]amino}methyl)oxolan-2-one

C15H21NO6 (311.1369)


   

(2s,3s,4s)-4-[(2e,5e)-6-carboxy-6-methylhexa-2,5-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2s,3s,4s)-4-[(2e,5e)-6-carboxy-6-methylhexa-2,5-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

2-hydroxy-3,6-dimethyl-n-(4,5,6-trihydroxy-4-methyloxan-3-yl)benzenecarboximidic acid

2-hydroxy-3,6-dimethyl-n-(4,5,6-trihydroxy-4-methyloxan-3-yl)benzenecarboximidic acid

C15H21NO6 (311.1369)


   

4-{[5-(2,3-dihydroxy-2-methylpropyl)-5-methyl-4-oxofuran-2-yl]methyl}-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-{[5-(2,3-dihydroxy-2-methylpropyl)-5-methyl-4-oxofuran-2-yl]methyl}-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H21NO6 (311.1369)


   

(2r,3r,4s,5r)-2-{6-[(2-hydroxyethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5r)-2-{6-[(2-hydroxyethyl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C12H17N5O5 (311.123)


   

(6s)-2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

(6s)-2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

C17H17N3O3 (311.127)


   

2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

2-hydroxy-6-[2-(3-methylimidazol-4-yl)-2-oxoethyl]-4,6-dihydro-3h-1-benzazocin-5-one

C17H17N3O3 (311.127)


   

adenosine,6n-2-hydroxyethyl

adenosine,6n-2-hydroxyethyl

C12H17N5O5 (311.123)


   

3-[3-(methoxycarbonyl)-9h-pyrido[3,4-b]indol-1-yl]-n-methylpropanimidic acid

3-[3-(methoxycarbonyl)-9h-pyrido[3,4-b]indol-1-yl]-n-methylpropanimidic acid

C17H17N3O3 (311.127)


   

(3r,4r,5s,6r,10z)-4,6-dihydroxy-2,3-dimethoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

(3r,4r,5s,6r,10z)-4,6-dihydroxy-2,3-dimethoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C15H21NO6 (311.1369)


   

4-{[(5r)-5-[(2r)-2,3-dihydroxy-2-methylpropyl]-5-methyl-4-oxofuran-2-yl]methyl}-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-{[(5r)-5-[(2r)-2,3-dihydroxy-2-methylpropyl]-5-methyl-4-oxofuran-2-yl]methyl}-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C15H21NO6 (311.1369)


   

4-(6-carboxy-6-methylhexa-1,5-dien-2-yl)-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

4-(6-carboxy-6-methylhexa-1,5-dien-2-yl)-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

4,6-dihydroxy-2,3-dimethoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

4,6-dihydroxy-2,3-dimethoxy-3-methyl-10-propylidene-2-azaspiro[4.5]dec-8-ene-1,7-dione

C15H21NO6 (311.1369)


   

(3r)-3-{[bis({[(3r)-2-oxooxolan-3-yl]methyl})amino]methyl}oxolan-2-one

(3r)-3-{[bis({[(3r)-2-oxooxolan-3-yl]methyl})amino]methyl}oxolan-2-one

C15H21NO6 (311.1369)


   

2-[2-(dimethylamino)-6-hydroxypurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[2-(dimethylamino)-6-hydroxypurin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C12H17N5O5 (311.123)


   

(2s,3s,4s)-4-[(2z,5e)-6-carboxy-6-methylhexa-2,5-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2s,3s,4s)-4-[(2z,5e)-6-carboxy-6-methylhexa-2,5-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)


   

(2s,3s,4s)-4-[(2z,4z,6r)-6-carboxy-6-methylhexa-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

(2s,3s,4s)-4-[(2z,4z,6r)-6-carboxy-6-methylhexa-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid

C15H21NO6 (311.1369)